Figure 5From: Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trialsForest plots for effect of mineralocorticoid receptor antagonists on serum indicators and functional capacity. (A) Quality of life changes; (B) 6-MWD changes; (C) PIIINP changes; (D) BNP changes. 6-MWD, 6-minute walk distance; BNP, B-type natriuretic peptide; CI, Confidence interval; KCCQ CSS, Kansas City Cardiomyopathy Questionnaire clinical summary score; PIIINP, Serum amino-terminal peptide of procollagen type-III; MLWHF, Minnesota Living with Heart Failure questionnaire; MRA, Mineralocorticoid receptor antagonist; WMD, Weighted mean difference.Back to article page